229 related articles for article (PubMed ID: 27456836)
1. Do Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes in Autoantibody-Positive TrialNet Subjects?
Fouts A; Pyle L; Yu L; Miao D; Michels A; Krischer J; Sosenko J; Gottlieb P; Steck AK;
Diabetes Care; 2016 Oct; 39(10):1738-44. PubMed ID: 27456836
[TBL] [Abstract][Full Text] [Related]
2. Electrochemiluminescence assays for insulin and glutamic acid decarboxylase autoantibodies improve prediction of type 1 diabetes risk.
Miao D; Steck AK; Zhang L; Guyer KM; Jiang L; Armstrong T; Muller SM; Krischer J; Rewers M; Yu L;
Diabetes Technol Ther; 2015 Feb; 17(2):119-27. PubMed ID: 25562486
[TBL] [Abstract][Full Text] [Related]
3. The Use of Electrochemiluminescence Assays to Predict Autoantibody and Glycemic Progression Toward Type 1 Diabetes in Individuals with Single Autoantibodies.
Sosenko JM; Yu L; Skyler JS; Krischer JP; Gottlieb PA; Boulware D; Miao D; Palmer JP; Steck AK
Diabetes Technol Ther; 2017 Mar; 19(3):183-187. PubMed ID: 28177779
[TBL] [Abstract][Full Text] [Related]
4. Association of High-Affinity Autoantibodies With Type 1 Diabetes High-Risk HLA Haplotypes.
Triolo TM; Pyle L; Broncucia H; Armstrong T; Yu L; Gottlieb PA; Steck AK
J Clin Endocrinol Metab; 2022 Mar; 107(4):e1510-e1517. PubMed ID: 34850014
[TBL] [Abstract][Full Text] [Related]
5. Simplifying prediction of disease progression in pre-symptomatic type 1 diabetes using a single blood sample.
Bediaga NG; Li-Wai-Suen CSN; Haller MJ; Gitelman SE; Evans-Molina C; Gottlieb PA; Hippich M; Ziegler AG; Lernmark A; DiMeglio LA; Wherrett DK; Colman PG; Harrison LC; Wentworth JM
Diabetologia; 2021 Nov; 64(11):2432-2444. PubMed ID: 34338806
[TBL] [Abstract][Full Text] [Related]
6. ECL-IAA and ECL-GADA Can Identify High-Risk Single Autoantibody-Positive Relatives in the TrialNet Pathway to Prevention Study.
Steck AK; Fouts A; Miao D; Zhao Z; Dong F; Sosenko J; Gottlieb P; Rewers MJ; Yu L;
Diabetes Technol Ther; 2016 Jul; 18(7):410-4. PubMed ID: 26991969
[TBL] [Abstract][Full Text] [Related]
7. Predicting progression to diabetes in islet autoantibody positive children.
Steck AK; Dong F; Frohnert BI; Waugh K; Hoffman M; Norris JM; Rewers MJ
J Autoimmun; 2018 Jun; 90():59-63. PubMed ID: 29395739
[TBL] [Abstract][Full Text] [Related]
8. Twenty-Year Progression Rate to Clinical Onset According to Autoantibody Profile, Age, and
Gorus FK; Balti EV; Messaaoui A; Demeester S; Van Dalem A; Costa O; Dorchy H; Mathieu C; Van Gaal L; Keymeulen B; Pipeleers DG; Weets I;
Diabetes Care; 2017 Aug; 40(8):1065-1072. PubMed ID: 28701370
[TBL] [Abstract][Full Text] [Related]
9. Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study.
Vehik K; Bonifacio E; Lernmark Å; Yu L; Williams A; Schatz D; Rewers M; She JX; Toppari J; Hagopian W; Akolkar B; Ziegler AG; Krischer JP;
Diabetes Care; 2020 Sep; 43(9):2066-2073. PubMed ID: 32641373
[TBL] [Abstract][Full Text] [Related]
10. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk.
Redondo MJ; Geyer S; Steck AK; Sharp S; Wentworth JM; Weedon MN; Antinozzi P; Sosenko J; Atkinson M; Pugliese A; Oram RA;
Diabetes Care; 2018 Sep; 41(9):1887-1894. PubMed ID: 30002199
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies.
Strollo R; Vinci C; Napoli N; Fioriti E; Maddaloni E; Åkerman L; Casas R; Pozzilli P; Ludvigsson J; Nissim A
Diabetes Metab Res Rev; 2019 May; 35(4):e3132. PubMed ID: 30693639
[TBL] [Abstract][Full Text] [Related]
12. Rising Hemoglobin A1c in the Nondiabetic Range Predicts Progression of Type 1 Diabetes As Well As Oral Glucose Tolerance Tests.
Vehik K; Boulware D; Killian M; Rewers M; McIndoe R; Toppari J; Lernmark Å; Akolkar B; Ziegler AG; Rodriguez H; Schatz DA; Krischer JP; Hagopian W;
Diabetes Care; 2022 Oct; 45(10):2342-2349. PubMed ID: 36150054
[TBL] [Abstract][Full Text] [Related]
13. Identical and Nonidentical Twins: Risk and Factors Involved in Development of Islet Autoimmunity and Type 1 Diabetes.
Triolo TM; Fouts A; Pyle L; Yu L; Gottlieb PA; Steck AK;
Diabetes Care; 2019 Feb; 42(2):192-199. PubMed ID: 30061316
[TBL] [Abstract][Full Text] [Related]
14. Unmethylated Insulin as an Adjunctive Marker of Beta Cell Death and Progression to Type 1 Diabetes in Participants at Risk for Diabetes.
Simmons KM; Fouts A; Pyle L; Clark P; Dong F; Yu L; Usmani-Brown S; Gottlieb P; Herold KC; Steck AK;
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31398795
[TBL] [Abstract][Full Text] [Related]
15. Single Islet Autoantibody at Diagnosis of Clinical Type 1 Diabetes is Associated With Older Age and Insulin Resistance.
Redondo MJ; Sosenko J; Libman I; McVean JJF; Tosur M; Atkinson MA; Becker D; Geyer S
J Clin Endocrinol Metab; 2020 May; 105(5):1629-40. PubMed ID: 31867614
[TBL] [Abstract][Full Text] [Related]
16. The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening.
Jacobsen LM; Bocchino L; Evans-Molina C; DiMeglio L; Goland R; Wilson DM; Atkinson MA; Aye T; Russell WE; Wentworth JM; Boulware D; Geyer S; Sosenko JM
Diabetologia; 2020 Mar; 63(3):588-596. PubMed ID: 31768570
[TBL] [Abstract][Full Text] [Related]
17. Combined positivity for HLA DQ2/DQ8 and IA-2 antibodies defines population at high risk of developing type 1 diabetes.
Decochez K; Truyen I; van der Auwera B; Weets I; Vandemeulebroucke E; de Leeuw IH; Keymeulen B; Mathieu C; Rottiers R; Pipeleers DG; Gorus FK;
Diabetologia; 2005 Apr; 48(4):687-94. PubMed ID: 15756536
[TBL] [Abstract][Full Text] [Related]
18. Proinsulin/Insulin autoantibodies measured with electrochemiluminescent assay are the earliest indicator of prediabetic islet autoimmunity.
Yu L; Dong F; Miao D; Fouts AR; Wenzlau JM; Steck AK
Diabetes Care; 2013 Aug; 36(8):2266-70. PubMed ID: 23423694
[TBL] [Abstract][Full Text] [Related]
19. Proinsulin:C-peptide ratio trajectories over time in relatives at increased risk of progression to type 1 diabetes.
Triolo TM; Pyle L; Seligova S; Yu L; Simmons K; Gottlieb P; Evans-Molina C; Steck AK
J Transl Autoimmun; 2021; 4():100089. PubMed ID: 33748733
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.
Pöllänen PM; Lempainen J; Laine AP; Toppari J; Veijola R; Vähäsalo P; Ilonen J; Siljander H; Knip M
Diabetologia; 2017 Jul; 60(7):1284-1293. PubMed ID: 28364254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
